Compare JSPR & BRLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JSPR | BRLT |
|---|---|---|
| Founded | 2018 | 2005 |
| Country | | US |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Consumer Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7M | 36.6M |
| IPO Year | N/A | 2021 |
| Metric | JSPR | BRLT |
|---|---|---|
| Price | $1.36 | $1.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | ★ $18.13 | $2.00 |
| AVG Volume (30 Days) | ★ 544.4K | 69.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $422,161,000.00 |
| Revenue This Year | N/A | $5.92 |
| Revenue Next Year | N/A | $4.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.11 | $1.26 |
| 52 Week High | $7.19 | $3.10 |
| Indicator | JSPR | BRLT |
|---|---|---|
| Relative Strength Index (RSI) | 45.41 | 35.46 |
| Support Level | $1.11 | $1.45 |
| Resistance Level | $1.38 | $1.54 |
| Average True Range (ATR) | 0.11 | 0.10 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 52.13 | 48.75 |
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.